 
                    
                KYONGBO PHARMACEUTICAL CO., LTD.
Manufactures APIs and finished drugs, offering global CDMO services from development to production.
214390 | KO
Overview
Corporate Details
- ISIN(s):
- KR7214390007
- LEI:
- Country:
- South Korea
- Address:
- 충청남도 아산시 실옥로 174, 아산시
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
Kyongbo Pharmaceutical Co., Ltd., established in 1987, is a pharmaceutical company specializing in the research, development, and manufacturing of Active Pharmaceutical Ingredients (APIs) and finished drug products. The company's portfolio includes general APIs, sterile APIs for cephalosporin and carbapenem injectables, and high-potency APIs for anticancer treatments. It also manufactures finished dosage forms, including solid oral drugs and sterile injectables. In addition to its own product lines, Kyongbo operates as a Contract Development and Manufacturing Organization (CDMO), providing integrated services from early-stage development through commercial cGMP production for a global client base. The company leverages its extensive experience and dedicated research facilities to innovate within the pharma-chemical sector.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2025-09-09 00:00 | Major Shareholding Notification 최대주주등소유주식변동신고서               | Korean | 50.4 KB | ||
| 2025-09-09 00:00 | Major Shareholding Notification 임원ㆍ주요주주특정증권등소유상황보고서 | Korean | 24.2 KB | ||
| 2025-09-09 00:00 | Major Shareholding Notification 주식등의대량보유상황보고서(일반) | Korean | 115.4 KB | ||
| 2025-08-14 00:00 | Interim Report 반기보고서 (2025.06) | Korean | 1021.1 KB | ||
| 2025-07-31 00:00 | Director's Dealing 임원ㆍ주요주주특정증권등거래계획보고서 | Korean | 41.0 KB | ||
| 2025-07-25 00:00 | Earnings Release 영업(잠정)실적(공정공시)               | Korean | 13.3 KB | ||
| 2025-07-09 00:00 | Legal Proceedings Report [기재정정]주요사항보고서(영업정지) | Korean | 13.0 KB | ||
| 2025-07-02 00:00 | Major Shareholding Notification 임원ㆍ주요주주특정증권등소유상황보고서 | Korean | 24.1 KB | ||
| 2025-07-02 00:00 | Major Shareholding Notification 최대주주등소유주식변동신고서               | Korean | 34.7 KB | ||
| 2025-07-02 00:00 | Major Shareholding Notification 주식등의대량보유상황보고서(일반) | Korean | 108.5 KB | ||
| 2025-06-19 00:00 | Major Shareholding Notification 임원ㆍ주요주주특정증권등소유상황보고서 | Korean | 24.6 KB | ||
| 2025-06-19 00:00 | Major Shareholding Notification 임원ㆍ주요주주특정증권등소유상황보고서 | Korean | 24.6 KB | ||
| 2025-06-18 00:00 | Legal Proceedings Report [기재정정]주요사항보고서(영업정지) | Korean | 13.4 KB | ||
| 2025-06-17 00:00 | Major Shareholding Notification 임원ㆍ주요주주특정증권등소유상황보고서 | Korean | 25.0 KB | ||
| 2025-06-17 00:00 | Major Shareholding Notification 최대주주등소유주식변동신고서               | Korean | 35.5 KB | 
Automate Your Workflow. Get a real-time feed of all KYONGBO PHARMACEUTICAL CO., LTD. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for KYONGBO PHARMACEUTICAL CO., LTD.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for KYONGBO PHARMACEUTICAL CO., LTD. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value | 
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
 
                                        
                                     
                                        
                                     
                                        
                                     
                                        
                                     
                                        
                                     
                                        
                                     
                                        
                                     
                                        
                                    